These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

516 related items for PubMed ID: 3511372

  • 1. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs.
    Austin HA, Klippel JH, Balow JE, le Riche NG, Steinberg AD, Plotz PH, Decker JL.
    N Engl J Med; 1986 Mar 06; 314(10):614-9. PubMed ID: 3511372
    [Abstract] [Full Text] [Related]

  • 2. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.
    Mok CC, Ying KY, Tang S, Leung CY, Lee KW, Ng WL, Wong RW, Lau CS.
    Arthritis Rheum; 2004 Aug 06; 50(8):2559-68. PubMed ID: 15334470
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G, Doria A, Mosca M, Alberighi OD, Ferraccioli G, Todesco S, Manno C, Altieri P, Ferrara R, Greco S, Ponticelli C.
    Clin J Am Soc Nephrol; 2006 Sep 06; 1(5):925-32. PubMed ID: 17699309
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of diffuse proliferative lupus glomerulonephritis: a comparison of two cyclophosphamide-containing regimens.
    Mok CC, Ho CT, Siu YP, Chan KW, Kwan TH, Lau CS, Wong RW, Au TC.
    Am J Kidney Dis; 2001 Aug 06; 38(2):256-64. PubMed ID: 11479150
    [Abstract] [Full Text] [Related]

  • 9. Effect of treatment on the evolution of renal abnormalities in lupus nephritis.
    Balow JE, Austin HA, Muenz LR, Joyce KM, Antonovych TT, Klippel JH, Steinberg AD, Plotz PH, Decker JL.
    N Engl J Med; 1984 Aug 23; 311(8):491-5. PubMed ID: 6749206
    [Abstract] [Full Text] [Related]

  • 10. Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide.
    Donadio JV, Holley KE, Ferguson RH, Ilstrup DM.
    N Engl J Med; 1978 Nov 23; 299(21):1151-5. PubMed ID: 309095
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Therapy of proliferative lupus glomerulonephritis: a prospective trial in The Netherlands.
    van den Wall Bake AW, Berden JH, Derksen RH, de Glas-Vos JW, Hagen EC.
    Neth J Med; 1994 Dec 23; 45(6):280-4. PubMed ID: 7838244
    [Abstract] [Full Text] [Related]

  • 13. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K, Yu Y, Tang Z, Liu Z, Li L.
    Chin Med J (Engl); 1997 Jul 23; 110(7):502-7. PubMed ID: 9594205
    [Abstract] [Full Text] [Related]

  • 14. Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.
    Arends S, Grootscholten C, Derksen RH, Berger SP, de Sévaux RG, Voskuyl AE, Bijl M, Berden JH, Dutch Working Party on systemic lupus erythematosus.
    Ann Rheum Dis; 2012 Jun 23; 71(6):966-73. PubMed ID: 22128082
    [Abstract] [Full Text] [Related]

  • 15. Longterm survival of lupus nephritis patients treated with azathioprine and prednisone.
    Barnett EV, Dornfeld L, Lee DB, Liebling MR.
    J Rheumatol; 1978 Jun 23; 5(3):275-87. PubMed ID: 372523
    [Abstract] [Full Text] [Related]

  • 16. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
    Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, Garrido Ed Ede R, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R.
    Arthritis Rheum; 2002 Aug 23; 46(8):2121-31. PubMed ID: 12209517
    [Abstract] [Full Text] [Related]

  • 17. Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only.
    Steinberg AD, Steinberg SC.
    Arthritis Rheum; 1991 Aug 23; 34(8):945-50. PubMed ID: 1859488
    [Abstract] [Full Text] [Related]

  • 18. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
    Mok CC, Ying KY, Ng WL, Lee KW, To CH, Lau CS, Wong RW, Au TC.
    Am J Med; 2006 Apr 23; 119(4):355.e25-33. PubMed ID: 16564783
    [Abstract] [Full Text] [Related]

  • 19. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
    Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, de Ramon Garrido E, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R.
    Arthritis Rheum; 2004 Dec 23; 50(12):3934-40. PubMed ID: 15593207
    [Abstract] [Full Text] [Related]

  • 20. Progressive lupus glomerulonephritis. Treatment with prednisone and combined prednisone and cyclophosphamide.
    Donadio JV, Holley KE, Ferguson RH, Ilstrup DM.
    Mayo Clin Proc; 1976 Aug 23; 51(8):484-94. PubMed ID: 950801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.